Nifedipine Tablet, Film Coated, Extended Release
Product Images NDC 68788-8164

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 68788-8164). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nifedipine Extended-release Tab Usp 60mg (Cda16a27 F029 40a6 A0e8 2bed0de71169 00)

Label for Nifedipine Extended-Release Tablets, USP 60 mg, generic for Procardia XL, film coated, extended release. The label shows the manufacturer as Ingenuus Pharmaceuticals, LLC and includes storage warnings and dosing instructions in both English and Spanish. The product is labeled for prescription use with packaging data fields for lot number, expiration date, and batch number.*

FDA Label Image

01 (Image 01)

Chemical structure diagram showing the molecular structure of nifedipine, the active ingredient in the product. The diagram includes a dihydropyridine ring with attached functional groups and a nitro-substituted benzene ring.*

FDA Label Image

02 (Image 02)

A data table comparing the percentages of adverse effects reported in a study between Nifedipine extended-release tablets and placebo. It lists headache, fatigue, dizziness, constipation, and nausea, showing respective percentages for each group along with the number of subjects (N=707 for Nifedipine, N=266 for placebo).*

FDA Label Image

03 (Image 03)

A data table comparing adverse effects between nifedipine capsules (N=226) and placebo (N=235). It lists percentages of patients experiencing effects such as dizziness, flushing, headache, weakness, nausea, muscle cramps, edema, nervousness, palpitations, dyspnea, and nasal congestion, with higher percentages often observed in the nifedipine group.*

FDA Label Image

04 (Image 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.